The Risk of Postoperative Wound Complications Following the Use of Negative Pressure Wound Therapy in Patients Undergoing Mastectomy
ALEX
1 other identifier
interventional
162
1 country
1
Brief Summary
To evaluate the risk of postoperative wound complications following the use of Avelle negative pressure wound therapy in patients undergoing mastectomy and flap fixation, which might serve as a basis for a randomized controlled trial
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started May 2019
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2019
CompletedFirst Posted
Study publicly available on registry
May 8, 2019
CompletedStudy Start
First participant enrolled
May 31, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedJuly 2, 2020
July 1, 2020
1 year
May 6, 2019
July 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with post-operative wound complications
Number of patients with post-operative wound complications defined as follows: 1. Surgical site infection (SSI) is defined as redness, pain, heat or swelling at the site of the incision or by the drainage of pus. Infection rate will be measured by A) the need for antibiotics, B) seroma aspiration due to infection or C) surgical drainage during the first three postoperative months. 2. Wound necrosis. Defined as a wound with necrotic tissue that consists of an accumulation of dead cells, tissue and cellular debris and often requires debridement. 3. Wound dehiscence or breakdown defined as a wound that ruptures along a surgical incision and the edges of the wound no longer align.
During the first three postoperative months
Secondary Outcomes (2)
Number of unplanned visits to the ER or breast cancer clinic
During the first three postoperative months
Number of patients with clinically significant seroma
During the first three postoperative months
Study Arms (2)
No negative pressure wound therapy
NO INTERVENTIONHistorical cohort: patients who underwent mastectomy with flap fixation using tissue glue and sutures and closed suction drainage and where negative wound pressure therapy has been omitted
Negative pressure wound therapy
EXPERIMENTALProspective cohort: patients who underwent mastectomy with flap fixation using tissue glue and sutures and closed suction drainage with negative wound pressure therapy
Interventions
Wound dressing with negative pressure on closed incisions
Eligibility Criteria
You may qualify if:
- Older than 18 years
- Female sex
- Indication for mastectomy or modified radical mastectomy
You may not qualify if:
- Patients undergoing breast conserving therapy
- Patients undergoing direct breast reconstruction
- Unable to comprehend implications and extent of study and sign for informed consent
- Participation in other study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zuyderland Medisch Centrum
Sittard, Limburg, 6162 BG, Netherlands
Related Publications (1)
De Rooij L, van Kuijk SMJ, van Haaren ERM, Janssen A, Vissers YLJ, Beets GL, van Bastelaar J. Negative pressure wound therapy does not decrease postoperative wound complications in patients undergoing mastectomy and flap fixation. Sci Rep. 2021 May 5;11(1):9620. doi: 10.1038/s41598-021-89036-3.
PMID: 33953312DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Surgeon, Principal Investigator, MD, PhD
Study Record Dates
First Submitted
May 6, 2019
First Posted
May 8, 2019
Study Start
May 31, 2019
Primary Completion
June 1, 2020
Study Completion
June 1, 2020
Last Updated
July 2, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share